UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1

Nature genetics, 1994-10, Vol.8 (2), p.136-140

1994

Volltextzugriff (PDF)

Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients

Neurology, 1994-05, Vol.44 (5), p.913-913

1994

Volltextzugriff (PDF)

Identification of two new KCNA1 mutations in episodic ataxia/myokymia families

Human molecular genetics, 1995-09, Vol.4 (9), p.1671-1672

1995

Volltextzugriff (PDF)

Apomorphine infusional therapy in parkinson's disease: Clinical utility and lack of tolerance

Movement disorders, 1995-01, Vol.10 (1), p.37-43

1995

Volltextzugriff (PDF)

Peripheral pharmacokinetics of apomorphine in humans

Annals of neurology, 1989-08, Vol.26 (2), p.232-238

1989

Volltextzugriff (PDF)

Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating parkinsonian patients

Neurology, 1987-06, Vol.37 (6), p.940-940

1987

Volltextzugriff (PDF)

Absorption of apomorphine by various routes in parkinsonism

Movement disorders, 1991, Vol.6 (3), p.212-216

1991

Volltextzugriff (PDF)

Does an inhibitory action of levodopa contribute to motor fluctuations?

Neurology, 1988-10, Vol.38 (10), p.1553-1553

1988

Volltextzugriff (PDF)

A 10-year follow-up--genotypic analysis disproves phenotypic classification

Movement disorders, 1997-05, Vol.12 (3), p.472-472

1997

Volltextzugriff (PDF)

Time course of tolerance to apomorphine in parkinsonism

Clinical pharmacology and therapeutics, 1992-11, Vol.52 (5), p.504-510

1992

Volltextzugriff (PDF)

Apomorphine tolerance in Parkinson's disease : lack of a dose effect

Clinical neuropharmacology, 1996-02, Vol.19 (1), p.59-64

1996

Volltextzugriff (PDF)

Differences in the motor response to apomorphine between untreated and fluctuating patients with Parkinson's disease

Clinical neuropharmacology, 1992-02, Vol.15 (1), p.13-18

1992

Volltextzugriff (PDF)

Controlled release levodopa/carbidopa 25/100 (sinemet CR 25/100) : pharmacokinetics and clinical efficacy in untreated parkinsonian patients

Clinical neuropharmacology, 1994-10, Vol.17 (5), p.429-434

1994

Volltextzugriff (PDF)

Pharmacodynamics of the hypotensive effect of levodopa in Parkinsonian patients

Clinical neuropharmacology, 1992-10, Vol.15 (5), p.365-374

1992

Volltextzugriff (PDF)

Digoxin prevents MPTP-induced dopamine depletion in mouse striatum

Neurotoxicology and teratology, 1997-09, Vol.19 (5), p.413-415

1997

Volltextzugriff (PDF)

The short-duration response to apomorphine: Implications for the mechanism of dopaminergic effects in parkinsonism

Annals of neurology, 1990-06, Vol.27 (6), p.660-665

1990

Volltextzugriff (PDF)

Motor fluctuations in parkinson's disease

Annals of neurology, 1989-06, Vol.25 (6), p.633-633

1989

Volltextzugriff (PDF)

Movement disorders in multiple sclerosis

Movement disorders, 1988, Vol.3 (2), p.109-116

1988

Volltextzugriff (PDF)

Does tolerance develop to levodopa? Comparison of 2-and 21-h levodopa infusions

Movement disorders, 1993, Vol.8 (2), p.139-143

1993

Volltextzugriff (PDF)

3-O-Methyldopa and the response to levodopa in Parkinson's disease

Annals of neurology, 1987-06, Vol.21 (6), p.584-588

1987

Volltextzugriff (PDF)

Effect of long-term therapy on the pharmacodynamics of levodopa. Relation to on-off phenomenon

Archives of neurology (Chicago), 1992-11, Vol.49 (11), p.1123

1992

Volltextzugriff (PDF)

Studies of renal function in animals chronically treated with apomorphine

Research communications in chemical pathology and pharmacology, 1989-10, Vol.66 (1), p.163

1989

Volltextzugriff (PDF)

Predictors of Outcomes in Patients With Mild Ischemic Stroke Symptoms: MaRISS

Stroke (1970), 2021-06, Vol.52 (6), p.1995-2004

2021

Volltextzugriff (PDF)

Diurnal responsiveness to apomorphine

Neurology, 1987-07, Vol.37 (7), p.1250-1250

1987

Volltextzugriff (PDF)

Parkinson's disease dyskinesias

Neurology, 1994-06, Vol.44 (6), p.1187; author reply 1187-1187

1994

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(66)

Publikationsform

Sprache

Englisch
(103)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(62)
Humans
(49)
Neurosciences & Neurology
(43)
Biological And Medical Sciences
(41)
Medical Sciences
(41)
Clinical Neurology
(38)
Male
(35)
Middle Aged
(31)
Female
(30)
Aged
(29)
Parkinson Disease - Drug Therapy
(28)
Pharmacology. Drug Treatments
(25)
Neuropharmacology
(22)
Anticonvulsants. Antiepileptics. Antiparkinson Agents
(18)
Parkinson Disease - Physiopathology
(16)
Adult
(15)
Levodopa - Therapeutic Use
(15)
Neurology
(15)
Neurosciences
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1

Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients

Identification of two new KCNA1 mutations in episodic ataxia/myokymia families

Apomorphine infusional therapy in parkinson's disease: Clinical utility and lack of tolerance

Peripheral pharmacokinetics of apomorphine in humans

Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating parkinsonian patients

Absorption of apomorphine by various routes in parkinsonism

Does an inhibitory action of levodopa contribute to motor fluctuations?

A 10-year follow-up--genotypic analysis disproves phenotypic classification

Time course of tolerance to apomorphine in parkinsonism

Apomorphine tolerance in Parkinson's disease : lack of a dose effect

Differences in the motor response to apomorphine between untreated and fluctuating patients with Parkinson's disease

Controlled release levodopa/carbidopa 25/100 (sinemet CR 25/100) : pharmacokinetics and clinical efficacy in untreated parkinsonian patients

Pharmacodynamics of the hypotensive effect of levodopa in Parkinsonian patients

Digoxin prevents MPTP-induced dopamine depletion in mouse striatum

The short-duration response to apomorphine: Implications for the mechanism of dopaminergic effects in parkinsonism

Motor fluctuations in parkinson's disease

Movement disorders in multiple sclerosis

Does tolerance develop to levodopa? Comparison of 2-and 21-h levodopa infusions

3-O-Methyldopa and the response to levodopa in Parkinson's disease

Effect of long-term therapy on the pharmacodynamics of levodopa. Relation to on-off phenomenon

Studies of renal function in animals chronically treated with apomorphine

Predictors of Outcomes in Patients With Mild Ischemic Stroke Symptoms: MaRISS

Diurnal responsiveness to apomorphine

Parkinson's disease dyskinesias

Suchergebnisse filtern